| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5691792 | Urology | 2017 | 6 Pages |
Abstract
We present the case of a 79-year-old man with an elevated postprostatectomy prostate-specific antigen level who was sequentially imaged with positron emission tomography/computed tomography (PET/CT) using 18F-fluciclovine followed by PSMA-targeted 18F-DCFPyL. Although both imaging tests successfully identified the same pelvic recurrence, each radiotracer had its relative merits. This case highlights the differences between these two PET radiotracers, which are increasingly being used to image men with recurrent prostate cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Michael A. Gorin, Kenneth J. Pienta, Martin G. Pomper, Steven P. Rowe,